Not applicableStudy completedNCT03348644What this trial is testingMilk Products in the Treatment of Hypophosphatemic RicketsWho this might be right forHypophosphatemic Rickets University of Aarhus 7
Not applicableLooking for participantsNCT06202027What this trial is testingPost Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean PatientsWho this might be right forFGF23-related Hypophosphataemic Rickets and Osteomalacia Kyowa Kirin Korea Co., Ltd. 100
Post-approval studies (Phase 4)Study completedNCT04842019What this trial is testingStudy to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLHWho this might be right forX-linked Hypophosphatemia (XLH) Kyowa Kirin Co., Ltd. 18
Not applicableAvailableNCT03775187What this trial is testingExpanded Access to BurosumabWho this might be right forX-linked HypophosphatemiaTumor-Induced Osteomalacia Kyowa Kirin Co., Ltd.
Not applicableStudy completedNCT04819490What this trial is testingA UK Multicentre, Health-Related Quality of Life Study for Children and Adolescents With XLHWho this might be right forX-Linked Hypophosphataemia Kyowa Kirin Pharmaceutical Development Ltd 32
Not applicableUnknownNCT06248632What this trial is testingEffect of Burosumab on the Inflammatory Profile of Patients With X-linked Hypophosphatemic Rickets FLAM-XLHWho this might be right forX-Linked Hypophosphatemic Rickets Hospices Civils de Lyon 20
Testing effectiveness (Phase 2)Study completedNCT04686175What this trial is testingEvaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 DeficiencyWho this might be right forEctonucleotide Pyrophosphatase/phosphodiesterase1 DeficiencyAutosomal Recessive Hypophosphatemic RicketsGeneralized Arterial Calcification of Infancy Inozyme Pharma 9
Large-scale testing (Phase 3)Study completedNCT02526160What this trial is testingStudy of KRN23 in Adults With X-linked Hypophosphatemia (XLH)Who this might be right forX-linked Hypophosphatemia Kyowa Kirin, Inc. 134
Very early researchStudy completedNCT03748966What this trial is testingCalcitriol Monotherapy for X-Linked HypophosphatemiaWho this might be right forX-linked HypophosphatemiaHypophosphatemic RicketsHypophosphatemic Rickets, X-Linked Dominant Massachusetts General Hospital 16
Testing effectiveness (Phase 2)Study completedNCT01340482What this trial is testingA Repeated Study of KRN23 in Adults With X-Linked HypophosphatemiaWho this might be right forX-linked Hypophosphatemia Kyowa Kirin Co., Ltd. 29
Not applicableUnknownNCT05312086What this trial is testingMuscle Abnormalities in Children With XLHWho this might be right forMuscle WeaknessXLH Assistance Publique - Hôpitaux de Paris 30
Not applicableStudy completedNCT03478839What this trial is testingStudy of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)Who this might be right forGeneralized Arterial Calcification of InfancyAutosomal Recessive Hypophosphatemic Rickets Type2 National Human Genome Research Institute (NHGRI) 48
Not applicableActive Not RecruitingNCT06302439What this trial is testingPROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 DeficiencyWho this might be right forEctonucleotide Pyrophosphatase/Phosphodiesterase 1 DeficiencyATP-Binding Cassette Subfamily C Member 6 Deficiency Inozyme Pharma 54
Not applicableStudy completedNCT02233322What this trial is testingIron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.Who this might be right forAutosomal Dominant Hypophosphatemic Rickets Indiana University 8
Large-scale testing (Phase 3)Active Not RecruitingNCT07473973What this trial is testingENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1 DeficiencyWho this might be right forEctonucleotide Pyrophosphatase/phosphodiesterase1 DeficiencyAutosomal Recessive Hypophosphatemic RicketsGeneralized Arterial Calcification of Infancy 1 Inozyme Pharma 12
Large-scale testing (Phase 3)Study completedNCT01237288What this trial is testingTherapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic RicketsWho this might be right forPrimary Hypophosphatemic Rickets Zeria Pharmaceutical 16
Testing effectiveness (Phase 2)Study completedNCT04188964What this trial is testingStudy to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of AgeWho this might be right forX-linked Hypophosphatemia (XLH) Kyowa Kirin Pharmaceutical Development Ltd 16
Large-scale testing (Phase 3)Study completedNCT00417612What this trial is testingEffectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic RicketsWho this might be right forHypophosphatemia, FamilialHyperparathyroidism Yale University 33
Testing effectiveness (Phase 2)Study completedNCT02163577What this trial is testingStudy of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)Who this might be right forX-linked Hypophosphatemia Kyowa Kirin, Inc. 52
Not applicableStudy completedNCT07745179What this trial is testingNatural History Study: ENPP1 Deficiency or the Early-Onset Form of ABCC6 DeficiencyWho this might be right forEctonucleotide Pyrophosphatase/phosphodiesterase1 DeficiencyATP-Binding Cassette Subfamily C Member 6 DeficiencyGeneralized Arterial Calcification of Infancy+2 more Inozyme Pharma 23